Chios Mastic Toothpaste and Halitosis and Oral Hygiene in Orthodontic Patients
Launched by UNIVERSITY OF ATHENS · Jan 3, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a special toothpaste made from mastic, a resin from the mastic tree, on bad breath (halitosis) and oral hygiene in teenagers who are undergoing orthodontic treatment with braces. The researchers want to see if using this toothpaste can reduce bad breath by measuring certain compounds related to it and also improve the cleanliness of teeth and gums in these young patients.
To participate in the trial, you need to be between 13 and 18 years old and currently wearing traditional braces on your upper and lower teeth for at least four months. You should also be in good health and have a specific level of bad breath as indicated by tests. However, you won't be eligible if you have dental issues like cavities or gum disease, smoke, have certain allergies, or have taken specific medications recently. If you join this study, you'll be helping researchers learn more about how mastic toothpaste can benefit young people with braces in keeping their mouths fresh and healthy.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Patients eligible for the trial must comply with all of the following at randomization:
- • • Age between 13 and 18 years for the group with conventional orthodontic appliances.
- • This age group represents the majority of patients seeking orthodontic treatment and is homogeneous regarding occupational status (high-school and lyceum students in Greece). Younger patients might present with cooperation problems.
- • Good general health.
- • Orthodontic fixed labial appliances on the maxillary and mandibular arch, brackets at least on 20 teeth for more than 4 months before enrollment and estimated duration of the treatment more than 1 month, bands on the first molars, extraction cases patients could be enrolled at least two months after the last extraction.
- • Total initial VSCs levels above the baseline level of 150ppb.
- Exclusion Criteria:
- Patients will be excluded for any of the following reasons:
- • Active caries
- • Periodontitis
- • Dental fluorosis / dysplasia of the teeth
- • Syndromes, mental disabilities and craniofacial deformities
- • Smoking or use of other tobacco products
- • Allergy to mastic
- • Antibiotics during the last 2 months
- • Chlorhexidine in the previous 3 weeks
- • Participation in other trials
About University Of Athens
The University of Athens, a leading institution in medical research and education, is dedicated to advancing healthcare through innovative clinical trials. With a robust infrastructure and a multidisciplinary team of experts, the university focuses on translating scientific discoveries into practical applications that benefit patient care. Its commitment to ethical standards and rigorous methodologies ensures that all trials conducted under its auspices adhere to the highest principles of research integrity. By fostering collaboration with national and international partners, the University of Athens aims to contribute significantly to the global medical community and improve health outcomes through evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Athens, Attiki, Greece
Patients applied
Trial Officials
Iosif Sifakakis, Associate Professor
Study Director
National and Kapodistrian Univrsity of Athens Greece
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported